Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.50
+0.04 (0.73%)
Nov 5, 2024, 11:14 AM EST - Market open
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 56 employees as of December 31, 2023.
Employees
56
Change
n/a
Growth
n/a
Revenue / Employee
$37,125
Profits / Employee
-$992,446
Market Cap
208.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nevro | 1,215 |
| Tenaya Therapeutics | 140 |
| Gossamer Bio | 135 |
| Senseonics Holdings | 132 |
| Cabaletta Bio | 103 |
| Nanobiotix | 102 |
| MediWound | 100 |
| Fulcrum Therapeutics | 76 |
OBIO News
- 3 months ago - Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 5 months ago - Orchestra BioMed to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 6 months ago - Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents - GlobeNewsWire
- 7 months ago - Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 8 months ago - Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors - GlobeNewsWire
- 8 months ago - Orchestra BioMed to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 8 months ago - Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients - GlobeNewsWire